Neuroblastoma notes in peads
Neuroblastoma is a type of cancer that develops from immature nerve cells found in several areas of the body, most commonly in the adrenal glands. It is the most common solid tumor in children under the age of 5. Here are some key points to note about neuroblastoma in pediatrics:
1. Presentation: Neuroblastoma can present in various ways, depending on the location and extent of the tumor. Common symptoms may include a lump or mass in the abdomen, bone pain, fever, weight loss, and changes in the eyes (such as drooping eyelids or unequal pupil size).
2. Diagnosis: Diagnosis of neuroblastoma typically involves a combination of imaging studies (such as ultrasound, CT scan, or MRI) and biopsy to confirm the presence of cancer cells. Additional tests may be done to determine the extent of the disease, such as bone marrow biopsy and MIBG scan.
3. Staging: Neuroblastoma is staged based on the International Neuroblastoma Staging System (INSS), which takes into account factors such as the size and location of the tumor, spread to lymph nodes and other organs, and the age of the child. Staging helps guide treatment decisions and predict outcomes.
4. Treatment: Treatment for neuroblastoma may involve a combination of surgery, chemotherapy, radiation therapy, and immunotherapy. The specific treatment plan will depend on factors such as the child's age, stage of the disease, and genetic characteristics of the tumor.
5. Prognosis: The prognosis for children with neuroblastoma can vary widely, depending on the stage of the disease and other factors. Children with low-risk neuroblastoma generally have a good prognosis, with high cure rates. However, those with high-risk disease may face a more challenging course of treatment and a lower chance of long-term survival.
6. Follow-up: Children who have been treated for neuroblastoma will require regular follow-up care to monitor for any signs of recurrence or long-term side effects of treatment. This may include imaging studies, blood tests, and physical exams over several years.
Overall, neuroblastoma is a complex disease that requires multidisciplinary care from a team of pediatric oncologists, surgeons, and other specialists. Advances in treatment have improved outcomes for many children with neuroblastoma, but ongoing research is needed to further understand and target this aggressive cancer.